Librofem

Ibuprofen, the active ingredient in Librofem, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is used to relieve mild to moderate pain, reduce fever, and treat inflammatory conditions in adults and children when appropriate. GNH USA supplies Librofem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Librofem (ibuprofen) acts on the cyclooxygenase pathway to manage pain, fever and inflammation. - Pain: provides relief of mild to moderate acute pain such as headache, dental or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory states. - Inflammatory conditions: reduces swelling and discomfort in disorders like osteoarthritis, rheumatoid arthritis and dysmenorrhea.

Adverse reactions may range from mild to serious, depending on individual susceptibility and duration of therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or heartburn. - Headache or dizziness. - Mild rash or itching. - Elevated blood pressure in susceptible patients.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hepatotoxicity with elevated liver enzymes. - Cardiovascular events including myocardial infarction or stroke. - Hematologic abnormalities like thrombocytopenia.

Before initiating Librofem, consider the following safety measures: - Assess gastrointestinal risk: avoid use in patients with active ulcers or a history of GI bleeding. - Evaluate renal function: monitor creatinine in patients with chronic kidney disease. - Monitor cardiovascular status: use the lowest effective dose in those with heart disease. - Avoid in known hypersensitivity to ibuprofen or other NSAIDs. - Use concomitant anticoagulants with caution and under medical supervision. - Store at ambient temperature: keep in the original container, protect from moisture and excessive heat.

Ibuprofen can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: synergistic ulcerogenic effect. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced renal clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: risk of reduced renal perfusion. - Selective serotonin reuptake inhibitors (SSRIs): additive bleeding risk. - Antihypertensive agents: may blunt blood pressure control. - Beta‑blockers: monitor for potential changes in heart rate.